Review the latest and currently developing knowledge of the critical issues around atrial fibrillation and related comorbidities and risks such as strokes, GI and gastroenterology involvement, and post-ablation bleeding Facilitate a focus on new technologies, recent research findings, and new procedures available for improved patient care Influence the development and use of procedures and treatments including but not limited to anti-fibrotic drugs, new EP techniques, and other pharmacologic agents Stimulate consensus building on treatment choices for recurrent arrhythmias before and after ablation, mobile health applications, ablation techniques, mapping, and other current and developing technologies and interventions
- Provider:HMP Education
- Activity Link: https://www.hmpglobalevents.com/wafib
- Start Date: 2025-02-27 06:00:00
- End Date: 2025-02-27 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 19.25 hours
AMA PRA Category 1 Credit™️: 19.25 hours
Nursing: 19.25 hours - Commercial Support: Source: Abbott (Any division) - Amount: 0 - Is Kind Support: False Source: AtriCure - Amount: 0 - Is Kind Support: False Source: Biosense Webster, Inc. - Amount: 0 - Is Kind Support: False Source: BIOTRONIK, Inc. - Amount: 0 - Is Kind Support: False Source: Boston Scientific Corporation - Amount: 0 - Is Kind Support: False Source: Sanofi S.A. - Amount: 0 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: Yes
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery